skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Accurate, expert and timely

accurate intelligence expertanalysis pharma intelligence

In a fast-growing sector like medical technology, access to accurate intelligence is key to success. Get the information you need to bring cutting-edge solutions to the fore with our suite of medtech solutions.

 

You’ll save research time and increase productivity with all your information from a single source. You can also reduce risk and stay compliant globally with coverage of the policy changes you need to know about.

 

How medtech solutions help

We can help you anticipate future technology needs, so you can make confident business decisions and plan strategically for the future.

  • Gain regular and detailed medical technology updates on policies from the FDA, EU, OUS and other global bodies
  • Identify upcoming device regulatory events/filings
  • Monitor drug delivery technologies and identify partnership opportunities
  • Stay abreast of company developments, including M&A, deals, financial results, partnerships and more
  • Track product developments, including clinical trials, results, approvals, launches and post-marketing updates

Our unique strengths

clinical research organizations

Understand the latest trends

​Access in-depth analysis of regulatory, legislative, legal and business developments in the medtech market. Plus, get reliable, real-time analysis of device markets, companies and products.
consultancies

Reduce risk

​Benefit from foresight on likely policy changes and understand why the medtech industry is under scrutiny.
marketing agencies

Stay abreast of commercial developments

​Keep up with financial developments in the sector: track company, product, market, growth and sales forecasts.

Increase profitability

Quantify market size, understand the device competitive landscape and monitor drug delivery technologies and identify partnership opportunities and unmet clinical needs.
View more
View Less

Relevant products

video-thumb-sample

Medtech Insight: global medical technology news & analysis

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Key benefits:

  • Real-time news and analysis
  • Regulatory development news
  • Company development news
video-thumb-sample

Meddevicetracker: medical device intelligence and forecasts

In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

Key benefits:

  • Real-time market intelligence
  • Medical device market coverage
  • Discover new opportunities
video-thumb-sample

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

  • Cutting edge thought leadership
  • Expert analysis
  • Hear from news makers

Pharma Intelligence latest insights

  • Medtech Insight

    Companion Diagnostics Webinar Recording

    By Derrick Gingery 24 May 2018

    Companion diagnostics are poised to be a huge growth area worldwide, with a CAGR of 20.1% over the next 5 years, making it a $6B industry by 2022. These often in-vitro medical devices provide essential information for the efficacy of a corresponding drug or biological product, and are also used for pre-determining the efficacy of treatment. Their growth is being propelled in most countries by a number of favorable factors.

    Topic Medtech

  • Medtech Insight

    Despite Only Two Parallel Review Success Stories, CMS Touts Better Coordination

    22 May 2018

    While only two devices have received approval and a national coverage determination through US FDA/CMS' parallel review program, a top CMS official says industry needs to look beyond just the numbers. Instead, she says the parallel review program is part of a sea-change that has allowed for better communication between CMS, FDA and sponsors.

    Topic FDA

  • Medtech Insight

    HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis of Contact-Force Catheter; LuxCath's OmniView; More Micra Results

    By Reed Miller 22 May 2018

    The 2018 Heart Rhythm Society scientific sessions in Boston covered a variety of presentations of new electrophysiology clinical data, including a report on the failure of St. Jude's Tendril leads, a meta-analysis of contact-force catheters for atrial-fibrillation ablation, and new data on Medtronic's Micra leadless pacemaker.

  • Medtech Insight

    Market Intel: Liquid Biopsies For Cancer Screening - Far From Reach Or Close At Hand?

    15 May 2018

    While liquid biopsy is becoming routine for cancer treatment stratification and monitoring, using blood tests to screen for early cancer in asymptomatic people remains a tantalizing target. Some question how practical such a test could be but several companies are already en route - some further down the road than others - to achieve this goal. Illumina spin-out Grail is one of these companies and while it is not alone, in a field where size matters, it may have an advantage. This article delves deeper into how these different technologies work and when they could reach the market

    Topic Cancer

  • Medtech Insight

    Belgium Ushers In Complex New Country-Specific Registration Requirements Pending Eudamed

    By Amanda Maxwell 15 May 2018

    Belgium is introducing new registration requirements for medical device and IVD operators June 17, ahead of the full application of the EU's medtech regulations and new Eudamed medical device database.

    Topic Business strategies

  • Meddevicetracker

    Meddevicetracker Weekly Roundup 23-02-18

    15 May 2018

    In this week's Meddevicetracker weekly roundup DarioHealth Launches the Dario Blood Glucose Monitoring System on Amazon Prime and Medtronic Introduces MiniMed Mio Advance Infusion Set for People with Diabetes.

  • Medtech Insight

    Start-Up Spotlight: Saluda Hopes To 'Evoke' From Down Under With First Closed-Loop Spine-Stim System

    By Bob Kronemyer 15 May 2018

    Aiming to improve the lives of patients living with chronic, intractable pain, Australian startup Saluda Medical Pty Limited is the first and only neuromodulation company in the world to develop a closed-loop spinal cord stimulation system (SCS). Unlike other SCS systems marketed today, Saluda’s device, currently in clinical trials, is designed to measure the spinal cord’s response to electrical stimulation, and then respond to patient's preferred stimulation.

  • Medtech Insight

    What We Know About Notified Body Appointments Useful Insights Into Timings And Capacity

    By Amanda Maxwell 15 May 2018

    When will notified bodies be appointed? How many will there be? Where are the problem areas? And what are the resource issues? MedTech Europe's Oliver Bisazza answers these and many more critical questions.

  • In Vivo

    Repositioning Market Access: A Function Fit For Purpose In A New Era Of Costly Cures

    By William Looney 15 May 2018

    On October 5, In Vivo convened a group of top market-access specialists and industry and investment analysts to consider a central strategic challenge facing all innovators in biopharma: how to pay for the next wave of cures. Finding the answer first depends on a rebranding of the function itself – it’s not market access to products; it’s patient access to progress.

    Topic Strategy

  • In Vivo

    Pharma Sourcing And Procurement: The New Strategy Of Spend

    11 May 2018

    Just what does a strategic approach to sourcing and procurement mean for today’s biopharma enterprise?In Vivotalks to the practice leaders at two diversely representative companies – Adamas Pharmaceuticals and Roivant Sciences – to identify four essential characteristics of “best in class” purchasing performance: (1) Think big – be strategic. (2) Buy better – add value.  (3) Work fast – spend forward. (4) Reach out earn the business.

    Topic BioPharmaceutical

  • In Vivo

    Business As Usual Is Not A Vision For The Future - The Value-Based Shift Is Underway

    By Ashley Yeo 11 May 2018

    Value is a concept that is increasingly embraced by providers and payers, as well as medtech manufacturers. Leading providers are organizing around value, changing their models and thereby inviting medtech manufacturers to adapt to the post fee-for-service era. Some, like Medtronic, are at the head of the game.

  • Medtech Insight

    US FDA Commissioner Agency Will Propose New Rule That Blends Quality System Regulation

    By Shawn M. Schmitt 11 May 2018

    Scott Gottlieb wrote in a May 9 blog post that the agency will propose a new rule that will blend its Quality System Regulation with international quality systems standard ISO 13485. Gottlieb claims the new rule would "harmonize domestic and international requirements, and modernize the regulation," while making sure that device-makers "adhere to high, internationally accepted quality systems."

    Topic Drug approval

  • Medtech Insight

    PureTechs Akili Scores $55M Investment For Video Game Therapies

    11 May 2018

    PureTech Health's subsidiary, Akili Interactive, has scored a $55m investment to bring its video game therapies for treating cognitive dysfunction closer to commercialization.

    Topic Digital Health

  • In Vivo

    Success in Oncology Infographic

    10 May 2018

    As events and developments in oncology rapidly shift and unfold, it’s more critical than ever to stay vigilant and agile to stay ahead.Understand these market disruptions and react to them with confidence with the data in Innovation in Oncology, the vital, free infographic from In Vivo.

    Topic Cancer

  • In Vivo

    Success In Oncology Whitepaper

    10 May 2018

    Looking for your path to success in oncology? Stay on top of the rapidly accelerating complexity of oncology drug development with the crucial insights into cancer treatments that only In Vivo can provide – now yours as a free download.

    Topic Cancer

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: